# US 2012/0251591 A1 · Polymer carrier

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251591 A1
- Document ID: US20120251591A1
- Status: Published application
- Kind: A1
- Application number: 13/450,790
- Filed: 2012-04-19
- Published: 2012-10-04
- Earliest claimed: 2007-06-18
- Assignees: Polytechnic Institute of New York University
- Inventors: Jin Kim Montclare; Man Xia Lee; Jennifer Haghpanah
- Web page: https://patentgrep.com/patent/US20120251591A1

## CPC

- A61K 9/1658: {Proteins, e.g. albumin, gelatin}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Compositions and methods for delivering bioactive agents, such as vitamins, hormones, nutrients and drugs, by stabilizing and or solubilizing these agents in a polymer matrix. The carrier polymers can be used in drug delivery and are useful for delivery of small molecules. The carrier polymers also can be used in scaffolds for regenerative medicine

## Claims

### Claim 1

A method for encapsulating hydrophobic small molecules comprising binding the hydrophobic small molecules to a non-collagenous protein to form a cartilage oligomeric matrix protein encapsulated hydrophobic small molecule.

### Claim 2 (depends on 1)

The method as claimed in claim 1, whereby the non-collagenous protein solubilizes and protects the hydrophobic small molecules from degradation.

### Claim 3 (depends on 1)

The method as claimed in claim 1, whereby the non-collagenous protein utilize regions composed of hydrophobic residues that form a hydrophobic pore with a threshold radius of 73 Å and a diameter that is 2-6 nm, this pore having the ability to store the hydrophobic small molecules.

### Claim 4 (depends on 1)

The method as claimed in claim 1, wherein the non-collagenous protein is cartilage oligomeric matrix protein or variants

### Claim 5 (depends on 1)

The method as claimed in claim 1, wherein the non-collagenous protein is combined with a fusion protein prior to binding with the hydrophobic small molecule.

### Claim 6 (depends on 1)

The method as claimed in claim 1, further comprising formulating the non-collagenous protein encapsulated hydrophobic small molecule with conventional pharmaceutical or veterinary mechanisms and materials in a form selected from the group consisting of powders, solutions, suspensions, and dispersions.

### Claim 7 (depends on 1)

The method as claimed in claim 1, further comprising formulating the non-collagenous protein encapsulated hydrophobic small molecule with emulsifiers, fatty acid esters, gelling agents, stabilizers, antioxidants, osmolality adjusting agents, buffers, preservatives, antimicrobial agents, and/or pH adjusting agents.

### Claim 8 (depends on 5)

The method as claimed in claim 5, wherein the fusion protein is selected from the group consisting of elastin, collagen, silk, and keratin based sequences.

### Claim 9 (depends on 1)

The method as claimed in claim 1, wherein the non-collagenous protein is in covalent conjugation to other biocompatible and biodegradable polymers or small molecules.

### Claim 10 (depends on 1)

The method as claimed in claim 1, further comprising stabilizing and/or solubilizing the hydrophobic small molecule in the non-collagenous protein.
